(Q38897636)

7 September 2017

title

Mesenchymal stromal cells overexpressing vascular endothelial growth factor in ovine myocardial infarction (English)

1 reference

7 September 2017

0 references

1 reference

8

R Laguens

1 reference

7 September 2017

P Locatelli

1

1 reference

7 September 2017

F D Olea

2

1 reference

7 September 2017

A Hnatiuk

3

1 reference

7 September 2017

A De Lorenzi

4

1 reference

7 September 2017

M Cerdá

5

1 reference

7 September 2017

C S Giménez

6

1 reference

7 September 2017

D Sepúlveda

7

1 reference

7 September 2017

A Crottogini

9

1 reference

7 September 2017

publication date

19 March 2015

1 reference

7 September 2017

1 reference

7 September 2017

volume

22

1 reference

7 September 2017

issue

6

1 reference

7 September 2017

page(s)

449-457

1 reference

Cell therapy for cardiac repair--lessons from clinical trials.

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Locally overexpressing hepatocyte growth factor prevents post-ischemic heart failure by inhibition of apoptosis via calcineurin-mediated pathway and angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Hypoxia-inducible vascular endothelial growth factor-engineered mesenchymal stem cells prevent myocardial ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Tissue inhibitor of matrix metalloproteinase-3 or vascular endothelial growth factor transfection of aged human mesenchymal stem cells enhances cell therapy after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Mesenchymal Stem Cell Therapy for Cardiac Repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Entrance in mitosis of adult cardiomyocytes in ischemic pig hearts after plasmid-mediated rhVEGF165 gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Cardiomyocyte hyperplasia after plasmid-mediated vascular endothelial growth factor gene transfer in pigs with chronic myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Effect of vascular endothelial growth factor gene transfer on infarct size, left ventricular function and myocardial perfusion in sheep after 2 months of coronary artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Efficient plasmid-mediated gene transfection of ovine bone marrow mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Arteriogenesis Induced by Intramyocardial Vascular Endothelial Growth Factor 165 Gene Transfer in Chronically Ischemic Pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Adeno-associated virus-mediated transduction of VEGF165 improves cardiac tissue viability and functional recovery after permanent coronary occlusion in conscious dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Dynamic induction of pro-angiogenic milieu after transplantation of marrow-derived mesenchymal stem cells in experimental myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Paracrine mechanisms in adult stem cell signaling and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Cardiac cell therapy: where we've been, where we are, and where we should be headed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Bioenergetic and Functional Consequences of Bone Marrow-Derived Multipotent Progenitor Cell Transplantation in Hearts With Postinfarction Left Ventricular Remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

High-dose plasmid-mediated VEGF gene transfer is safe in patients with severe ischemic heart disease (Genesis-I). A phase I, open-label, two-year follow-up trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Impact of timing on efficacy and safetyof intracoronary autologous bone marrow stem cells transplantation in acute myocardial infarction: a pooled subgroup analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

Hypertension impairs postnatal vasculogenesis: role of antihypertensive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function.

21 January 2018

1 reference

12 December 2020

Genetically Engineered Mesenchymal Stem Cells Influence Gene Expression in Donor Cardiomyocytes and the Recipient Heart

1 reference

12 December 2020

Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials

1 reference

12 December 2020

Reference values for echocardiographic parameters and indexes of left ventricular function in healthy, young adult sheep used in translational research: comparison with standardized values in humans

1 reference

12 December 2020

The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction

1 reference

12 December 2020

Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group

1 reference

12 December 2020

Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures

1 reference

12 December 2020

Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction

1 reference

12 December 2020

Mesenchymal stromal cells: current understanding and clinical status

1 reference

12 December 2020

The relative role of subendocardium and subepicardium in left ventricular mechanics

1 reference

12 December 2020

Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI

1 reference

12 December 2020

1 reference

12 December 2020

Progressive ventricular remodeling in rat with myocardial infarction

1 reference

12 December 2020

Histopathologic time course of myocardial infarct in rabbit hearts

1 reference

12 December 2020

Left ventricular remodeling after myocardial infarction: past, present, and future

1 reference

12 December 2020

An ovine model of postinfarction dilated cardiomyopathy in animals with highly variable coronary anatomy

1 reference

12 December 2020

Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry

1 reference

https://api.crossref.org/works/10.1038%2FGT.2015.28

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/GT.2015.28

1 reference

7 September 2017

1 reference